Woodline Partners’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$348K Sell
127,028
-2
-0% -$6 ﹤0.01% 991
2025
Q4
$470K Sell
127,030
-255,057
-67% -$824K ﹤0.01% 909
2025
Q3
$1.01M Sell
382,087
-1,121,667
-75% -$2.17M ﹤0.01% 802
2025
Q2
$1.48M Hold
1,503,754
0.01% 761
2025
Q1
$2.17M Buy
1,503,754
+8
+0% +$15 0.01% 651
2024
Q4
$3.31M Sell
1,503,746
-740,614
-33% -$1.73M 0.02% 568
2024
Q3
$3.7M Sell
2,244,360
-2,805,448
-56% -$5.66M 0.03% 426
2024
Q2
$11.2M Sell
5,049,808
-2,872,421
-36% -$6.76M 0.11% 235
2024
Q1
$21.2M Buy
7,922,229
+7,631,847
+2,628% +$18.5M 0.2% 163
2023
Q4
$868K Buy
+290,382
New +$377K 0.01% 411
2023
Q2
Sell
-423,814
Closed -$674K 674
2023
Q1
$674K Hold
423,814
0.01% 506
2022
Q4
$2.64M Sell
423,814
-771,891
-65% -$5.52M 0.04% 436
2022
Q3
$8.01M Buy
1,195,705
+351,070
+42% +$2.41M 0.11% 226
2022
Q2
$5.37M Buy
+844,635
New +$4.79M 0.08% 250

Other funds holding ESPR